Safety and Efficacy Study of Novel Gene Therapy ZM-02 for Retinitis Pigmentosa Patients

Conditions: Retinitis Pigmentosa Interventions: Drug: ZM-02-L; Drug: ZM-02-H; Procedure: ZM-02-S Sponsors: Zhongmou Therapeutics Not yet recruiting

Source: ClinicalTrials.gov - March 5, 2024 Category: Research Source Type: clinical trials